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Abstract
Aminopeptidase N (CD13) is a widely expressed cell surface metallopeptidase involved in
the migration of cancer and endothelial cells. Apart from our demonstration that CD13 mod-
ulates the efficacy of tumor necrosis factor-α-induced apoptosis in neutrophils, no other
function for CD13 has been ascribed in this cell. We hypothesized that CD13 may be
involved in neutrophil migration and/or homotypic aggregation. Using purified human blood
neutrophils we confirmed the expression of CD13 on neutrophils and its up-regulation by
pro-inflammatory agonists. However, using the anti-CD13 monoclonal antibody WM-15 and
the aminopeptidase enzymatic inhibitor bestatin we were unable to demonstrate any direct
involvement of CD13 in neutrophil polarisation or chemotaxis. In contrast, IL-8-mediated
neutrophil migration in type I collagen gels was significantly impaired by the anti-CD13
monoclonal antibodies WM-15 and MY7. Notably, these antibodies also induced significant
homotypic aggregation of neutrophils, which was dependent on CD13 cross-linking and
was attenuated by phosphoinositide 3-kinase and extracellular signal-related kinase 1/2
inhibition. Live imaging demonstrated that in WM-15-treated neutrophils, where homotypic
aggregation was evident, the number of cells entering IL-8 impregnated collagen I gels was
significantly reduced. These data reveal a novel role for CD13 in inducing homotypic aggre-
gation in neutrophils, which results in a transmigration deficiency; this mechanism may be
relevant to neutrophil micro-aggregation in vivo.
Introduction
Neutrophils are critical effector cells of the innate immune response and recruited to sites of
tissue injury in response to locally generated chemoattractants. Neutrophil migration is a
highly regulated process involving complex interactions with the vascular endothelium and
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tissue stroma. In addition to adhering to the endothelium and their known interactions with
platelets, neutrophils also have the capacity to self-associate, a process known as homotypic
aggregation (HA) [1]. Physiologically this is believed to contribute to the intravascular pathol-
ogy associated with disease states such as sepsis [2]. Hence, neutrophil HA can lead to the for-
mation of occlusive plugs within the microcirculation causing tissue hypoxia, hypo-perfusion
and endothelial damage [2, 3].
Aminopeptidase N or CD13 is a multifunctional and widely expressed membrane-bound
zinc-binding metallopeptidase [4]. CD13 participates in the migration and invasion of cancer
and endothelial cells as evidenced in chemotaxis, haptotaxis and extracellular matrix (ECM)
invasion assays [5–9]. In these studies overexpression of CD13 has been shown to enhance
migration and invasion whilst inhibition of the aminopeptidase impairs these responses. Fur-
thermore, cell invasion into reconstituted basement membrane (BM) with consequent degra-
dation of type IV collagen requires CD13 [5]. Evidence suggests that the enzymatic activity of
CD13 is fundamental for promoting cancer and endothelial cell migration and invasion [6, 10].
CD13 also functions as a homotypic adhesion molecule. It mediates monocyte-monocyte and
monocyte-endothelial adhesion in response to anti-CD13 monoclonal antibody (mAb) cross-
linking on the cell surface [11, 12]. Downstream activation of signal transduction pathways
occurs following antibody binding and recent evidence suggests participation by CD13 itself in
signalling pathways [11–13].
Human granulocytes express CD13 on their cell surface [14, 15] and we have previously
shown the existence of an inverse correlation between neutrophil CD13 activity and the pro-
apoptotic efficacy of tumor necrosis factor-α (TNF-α), and the ability of CD13 inhibitors to
enhance this response [16]. However, this is the only reported function of CD13 in human neu-
trophils. This study was designed to evaluate the role of CD13 in regulating migration and HA
in human neutrophils. We demonstrate the novel observation of neutrophil HA in response to
anti-CD13 mAbs and a resultant reduction in chemoattractant-induced migration through col-
lagen I.
Materials and Methods
Isolation of human neutrophils
Neutrophils were isolated from the blood of healthy adult volunteers using dextran sedimenta-
tion and discontinuous plasma Percoll™ gradients or a 2-step density gradient consisting of
Histopaque1-1119 and 1077 (Sigma-Aldrich) as described [17, 18].
Ethics statement
These studies were approved by the Cambridge Research Ethics Committee and the Science,
Technology, Engineering and Mathematical Ethical Review Committee of the University of
Birmingham. Written informed consent was obtained from all participants and all studies
complied with the Declaration of Helsinki.
Determination of neutrophil CD13 expression
Neutrophils (5 x 106/ml in phosphate buffered saline with cations (PBS+, Sigma-Aldrich))
were stimulated with N-formylmethionyl-leucyl-phenylalanine (fMLP, 100 nM; Sigma-
Aldrich), interleukin-8 (IL-8), TNF-α (100 ng/ml and 10 ng/ml respectively; R&D Systems) or
buffer for 10 or 30 min. Cells were incubated with 100 μl phosphate buffered saline without cat-
ions (PBS-, Sigma-Aldrich) containing 5 μl mouse anti-human CD13 fluorescein isothiocya-
nate (FITC)-conjugated antibody (Clone WM-47; Millipore UK Ltd, FCMAB180F) or an
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isotype control for 30 min and analysed by flow cytometry (FACSCalibur™, BD Biosciences).
Mean fluorescence values were calculated from 10,000 events per sample using FLOWJO 7.2.5
software (Tree Star, Inc. Ashland, USA).
Assessment of CD13 activity
CD13 enzymatic activity was determined as described [16]. Neutrophils (5 x 106/ml in PBS+)
were pre-incubated with bestatin (0.1 mM; Sigma-Aldrich) and the monoclonal mouse anti-
human CD13 antibodies WM-15 (8 μg/ml; AbD Serotec, MCA1270EL), MY7 (5 μg/ml; Beck-
man Coulter, 6602626) andWM-47 (1:40 (v/v); Santa Cruz Biotechnology Inc, SC-18891 and
Accurate Chemical & Scientific Corp, BYA9643-1) for 30 min. Recombinant human CD13
(rCD13) (200 ng/ml; R&D Systems) was incubated with a concentration range of bestatin (0,
0.001, 0.01, 0.1, 1 mM) for 30 min. Cleavage of the substrate L-Alanine 4-nitroanilide (2 mM;
Sigma-Aldrich) was measured over 60 min.
Neutrophil shape change assay
Neutrophils (5 x 106/ml in PBS+) were pre-incubated with bestatin (0.1 mM), WM-15 (8 μg/
ml), WM-47 (1:40 (v/v)) for 30 min prior to stimulation with fMLP or IL-8 for 10 min. Reac-
tions were stopped by the addition of BD CellFIX™ (BD Biosciences). The percentage of gated
neutrophils that had shifted in FSC-H compared to control unstimulated cells was used to
determine the degree of shape change (FACSCalibur™). Ten thousand events were collected for
each sample and data analysed using FLOWJO 7.2.5 software.
Neutrophil migration
Neutrophil chemotaxis was assessed using ChemoTx1microplates with a polyvinylpyrroli-
done-treated 5 μm pore polycarbonate filter (Neuro Probe1, Inc) as described [19]. Neutro-
phils (5 x 106/ml in Iscove’s modified Dulbecco’s medium (IMDM, Invitrogen) containing 1%
(v/v) autologous serum (AS)) were pre-incubated with bestatin (0.1 mM), WM-15 (8 μg/ml),
WM-47 (1:40 (v/v)) or buffer for 30 min. Fifty μl of cell suspension was added to each test site
on the filter. Migration towards a concentration range of IL-8 (29 μl per well) was quantified
after 90 min by counting the number of neutrophils in the lower well using a haemocytometer.
Migration through collagen I (75 μl of 2 mg/ml) was assessed using 6.5 mm Transwell1
inserts containing a 5 μm pore polycarbonate filter (Sigma-Aldrich). Gels were prepared
according to BD Biosciences ‘Alternate Gelation Procedure for Rat Tail Collagen I’. Neutro-
phils (6.25 x 105 in 125 μl) were pre-incubated as above for 10 min, in addition to IgG1 (8 μg/
ml; R&D Systems, MAB002) and MY7 (5 μg/ml). Migration to IL-8 (650 μl of 100 ng/ml) was
quantified in the lower well after 9 hr using a haemocytometer.
Neutrophil migration into collagen I gels was quantified using a phase-contrast microscope
with a motorised Z-focus and digital camera using Image-Pro Plus software (Media Cybernet-
ics, UK) as described [20]. All manipulations of gels and microscopy were carried out at 37°C.
Collagen I (800 μl in 24 well plates) was equilibrated over 24 hr with an equal volume of IL-8
(100 ng/ml) or Medium-199 (M199, Invitrogen). Fresh M199 was added 30 min prior to neu-
trophil addition to create a chemoattractant gradient. Neutrophils (1.25 x 105/ml in M199 con-
taining 0.15% (w/v) bovine serum albumin (BSA, Sigma-Aldrich)) were pre-incubated for 10
min with CD13 inhibitors. Digitised Z-stack images were acquired at 3 μm steps, stacking
down from the gel surface in four random fields at 30 and 60 min and analysed offline using
the same software. The average depth of penetration and the proportion of added cells entering
the gel were calculated as described [20].
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Measurement of neutrophil HA
Neutrophils (5 x 106/ml in IMDM containing 1% (v/v) AS) were added to CD13 inhibitors and
100 μl and 200 μl aliquots placed in 96 well flexible plates or 2 ml safe-lock tubes respectively.
Fab fragments of WM-15 were prepared using the Pierce™Mouse IgG1 Micro Preparation Kit.
Fragmentation was confirmed by SDS-PAGE. Goat anti-mouse (GAM) F(ab)’2 fragments (5 μg/
ml; Sigma-Aldrich, M0284) were added following a 30 min pre-incubation withWM-47. To
assess the effect of kinase and actin polymerisation inhibitors, neutrophils were pre-incubated
for 15 or 30 min with LY294002 (10 μM; Cayman Chemical), UO126 (10 μM; Calbiochem) or
cytochalasin-D (2 μM; Sigma-Aldrich). Light microscopy assessment of HA was undertaken by
capturing well images at the time points indicated using Image-Pro Plus software and quantify-
ing aggregate area using Image J 1.44 software (National Institutes of Health, USA).
Flow cytometry assessment of HA was undertaken after 30 min at 400 rpm (Thermomixer
comfort). Reactions were terminated by the addition of BD CellFIX™ and gated neutrophils
divided into singlets and non-singlets using SSC and FSC area dot plots (LSRFortessa™, BD
Biosciences). Non-singlets correspond to those particles with high SSC and FSC area [21]. To
corroborate the distinction between singlets and non-singlets, the gated neutrophils were also
separated by SSC width and SSC height dot plots. Ten thousand events per sample were exam-
ined and data analysed using FLOWJO 7.2.5 software.
rCD13 adhesion assay
A 96 well ELISA microplate was coated with rCD13 (1000 ng/ml) or PBS- (vehicle control)
overnight at 4°C. The plate was washed three times and blocked with 1% (w/v) BSA solution
for 2 hr at room temperature. Neutrophils (1 x 106/ml in IMDM containing 1% (v/v) AS) were
pre-incubated with WM-15 (8 μg/ml) or control for 10 min and 200 μl of cell suspension
added to each well in duplicate for 20 min. Plates were washed three times with PBS- and the
number of adherent neutrophils was assessed by light microscopy at 100x magnification.
Statistical analysis
Data represent the mean ± standard error of the mean (SEM) if n 3 or mean ± standard devi-
ation (SD) if n = 2. Differences between groups were assessed using repeated measures one-
way analysis of variance (ANOVA) with Tukey’s analysis for multiple comparisons or Dun-
nett’s analysis for comparison with control data. Two-way ANOVA with a Bonferroni post test
was used to assess multiple treatments over time. Effects of single treatments were analysed by
the Student’s paired and unpaired t test. Data were analysed using Prism 5.0 software (Graph-
Pad, San Diego, CA). A P value of< 0.05 was considered to be significant.
Results and Discussion
Neutrophil expression of CD13
Freshly isolated human neutrophils show clear expression of CD13, as determined by flow
cytometry, and the level of expression was increased at 30 min following fMLP, IL-8 or TNF-α
stimulation (Fig 1). The increase in expression at the cell surface could be detected as early as 10
min and was approximately twice that of baseline regardless of the agonist used (Fig 1 and S1
Fig). This confirms previously published work demonstrating cell surface expression of CD13
on human granulocyte populations and an enhancement of expression following agonist stimu-
lation [15]. CD13 has been isolated from secretory vesicles of neutrophils, which are mobilised
rapidly in response to a wide variety of inflammatory stimuli [22]. The presence of pre-formed
CD13 may explain the swift increase in cell surface expression observed in this study.
CD13 and Homotypic Aggregation Neutrophils
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Inhibition of CD13 enzymatic activity
Inhibition of the aminopeptidase activity of CD13 can be achieved by chemical inhibitors or
specific antibodies. Bestatin (0.1 mM), a small molecular weight peptide that binds competi-
tively to the active site of CD13, inhibited 51.2% of measured CD13 activity (Fig 2A). This
apparent ‘residual CD13 activity’ may be explained by the presence of other (bestatin resistant)
cell surface peptidases that are capable of degrading the CD13 substrate and/or the substrate is
able to enter the cell and be cleaved by cytosolic peptidases. The demonstration that bestatin
inhibits 96.7% of rCD13 activity (at a concentration with equivalent activity to neutrophils in
suspension) supports this view and confirms effective inhibition of CD13 (Fig 2B). WM-15, a
monoclonal anti-human CD13 antibody, has also been shown to inhibit the enzymatic activity
Fig 1. Neutrophil cell surface expression of CD13. Neutrophils were stimulated with fMLP (100 nM), IL-8
(100 ng/ml), TNF-α (10 ng/ml) or vehicle control for 30 min. Representative histograms (A) with quantification
of mean fluorescence intensity (MFI) (after subtraction of the isotype control) are shown (B). Data represent
the mean ± SEM of n = 3 independent experiments each performed in duplicate. ***, P < 0.001 vs. control,
by repeated measures ANOVA/ Dunnett’s test.
doi:10.1371/journal.pone.0160108.g001
Fig 2. Effect of CD13 ligation on neutrophil and recombinant human CD13 activity.Neutrophils were pre-
incubated with bestatin (0.1 mM), anti-CD13 mAbWM-15 (8 μg/ml), anti-CD13 mAbMY7 (5 μg/ml), anti-CD13
mAbWM-47 (1:40 v/v) or vehicle control for 30 min. Cleavage of L-Alanine 4-nitroanilide (2 mM) was measured
over 60 min and is expressed as a percentage of the activity observed with control treated cells. Data represent
the mean ± SEM of n = 7 (Bestatin), n = 3 (WM-15 andWM-47) or mean ± SD of n = 2 independent experiments
(MY7) each performed in triplicate (A). rCD13 (200 ng/ml) was pre-incubated alone or with increasing
concentrations of bestatin for 30 min. Cleavage of L-Alanine 4-nitroanilide was measured over 60 min and
converted to nmol substrate/min. The mean ± SEM from three independent experiments, each performed in
triplicate, are shown. (B). ***, P < 0.001, **, P < 0.01, ns, non-significant vs. control, by Student’s paired t test.
doi:10.1371/journal.pone.0160108.g002
CD13 and Homotypic Aggregation Neutrophils
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of CD13 on human neutrophils and a comparable degree of inhibition was demonstrated in
this study (Fig 2A) [16]. The CD13 mAbMY7 has been reported to partially inhibit CD13 ami-
nopeptidase activity on U-937 cells [11]. In contrast, the CD13 mAbWM-47 has no effect on
CD13 enzymatic activity and can be utilised as a selective CD13 control antibody [11]. The
degree of enzyme inhibition conferred by MY7 and WM-47 on human neutrophils was 15%
and 2.1% respectively, consistent with U-937 cells (Fig 2A) [11]. Epitope mapping studies have
demonstrated that WM-15 binds to the zinc-binding domain of CD13 and MY7 binds to a dis-
tinct but closely located epitope [23]. WM-47 binds to an epitope separate from the enzymatic
active site, explaining the difference in enzymatic inhibitor efficacy of the mAbs [23].
Role of CD13 in neutrophil polarisation and chemotaxis
Chemoattractants are produced by host cells in response to pathogens or injury and are
required for the directed movement of neutrophils to sites of infection or inflammation. Neu-
trophil shape change or polarisation is a pre-requisite for chemotaxis and can be assessed by
non-gradient chemokine challenge [24]. To determine whether CD13 has a role in regulating
neutrophil polarisation and chemotaxis, the effect of two inhibitors of CD13 aminopeptidase
activity were assessed. Pre-incubating neutrophils with bestatin, WM-15 or the control mAb
WM-47, did not modify either the extent or concentration-dependence of chemoattractant-
induced neutrophil chemotaxis when measured in a two-dimensional (2D) filter assay, or neu-
trophil polarisation (Fig 3A, 3B, 3C and 3D). Both of these assays have been validated exten-
sively in neutrophils by our and other groups [19, 25].
The demonstration that CD13 enzymatic inhibition did not impair chemoattractant-
induced neutrophil polarisation or chemotaxis contrasts with studies in endothelial and cancer
cells. Neutrophil cell surface expression of CD13 is reportedly lower than for certain other cell
types and one could speculate that a critical level of CD13 expression is required for 2D migra-
tion and that this is not attained in purified human neutrophils [14]. In support of this, Terau-
chi et al. have shown that although bestatin inhibits the migration of CD13 expressing ovarian
carcinoma cells, it does not influence the migration of ovarian carcinoma cells with a low level
of CD13 expression [9].
Role of CD13 in neutrophil migration through collagen
Having crossed the venule wall, neutrophils must migrate through the three-dimensional (3D)
interstitial matrix en route to the site of inflammation. Collagen I is the predominant collagen
type present within the interstitium and hence neutrophil migration through a collagen I gel in
the presence of bestatin andWM-15 was assessed using a Transwell1 assay. A second CD13
mAb, MY7, which has been shown to have limited CD13 enzymatic inhibitor efficacy was also
examined. As shown in Fig 3E and 3F neutrophil migration through a 3D collagen I matrix in
response to IL-8 was significantly impaired in the presence of WM-15 and MY7. The chemical
enzymatic inhibitor bestatin had no effect suggesting that, in contrast to cancer and endothelial
cell invasion, the attenuation in neutrophil migration mediated by WM-15 and MY7 was inde-
pendent of CD13 enzymatic inhibition. This led us to investigate possible enzymatic indepen-
dent functions of WM-15 and MY7 on human neutrophils.
Role of CD13 in neutrophil homotypic aggregation
Aside from its enzymatic activities, CD13 can function as a homotypic adhesion molecule.
Using the pro-monocytic cell line U-937, Mina-Osorio and colleagues demonstrated HA in
response to the anti-CD13 antibodies 452, WM-15 and MY7 [11].
CD13 and Homotypic Aggregation Neutrophils
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To examine the role of CD13 in neutrophil HA a semi-quantitative method using light
microscopy and a quantitative method using flow cytometry were employed (Fig 4B, 4C and
4D). As shown in Fig 4A and 4CWM-15 resulted in a significant HA response of purified
human neutrophils with aggregation peaking at 60 min. The time course of WM-15-induced
neutrophil HA was longer than that observed for chemoattractant-induced HA, which pro-
ceeds rapidly and is reversible over a number of minutes [1]. Incubation at 4°C abolished WM-
15-induced aggregation (Fig 4A). Neutrophils incubated with WM-15 and MY7 also demon-
strated a significant HA response as assessed by flow cytometry (Fig 4E). This effect was reca-
pitulated using SSC width by SSC height flow dot plots (Fig 4F). Distinguishing cell aggregates
Fig 3. Effect of CD13 ligation on neutrophil shape change andmigration. Neutrophils were pre-
incubated with bestatin (0.1 mM), WM-15 or IgG1 (8 μg/ml), WM-47 (1:40 v/v), MY7 (5 μg/ml) or vehicle
control for 30 min (A, B, C and D) or 10 min (E and F). Cells were stimulated in triplicate with a concentration
range of fMLP or IL-8 for 10 min and percentage shape change assessed by flow cytometry (A and B).
Chemotaxis was assessed in duplicate using a ChemoTx1 plate and migration towards a concentration
range of IL-8 quantified after 90 min by manual counting (C and D). Migration through collagen I, gelled in a
Transwell1 insert, towards IL-8 (100 ng/ml) was quantified in duplicate after 9 hr and is expressed as a
percentage of the migration observed with control treated cells (E and F). Data represent the mean ± SEM of
n = 3 independent experiments (A, C, D, E and F) or mean ± SD of n = 2 independent experiments (B). ***,
P < 0.001, *, P < 0.05, ns, non-significant vs. control, by repeated measures ANOVA/Tukey’s test.
doi:10.1371/journal.pone.0160108.g003
CD13 and Homotypic Aggregation Neutrophils
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by SSC/FSC area dot plots of gated cellular events and, for corroboration, SSC width/SSC
height dot plots has been established by other investigators [21, 26, 27]. The chemical enzy-
matic inhibitor bestatin, the CD13 mAbWM-47 and an IgG1 isotype control antibody did not
induce neutrophil HA (Fig 4A, 4E and 4F).
The observation that CD13 participates in neutrophil HA has not previously been
described. Similar to the pro-monocytic cell line U-937, HA was not observed with the enzy-
matic inhibitor bestatin or WM-47 [11]. The fact that specific CD13 antibodies induced HA in
comparison to the isotype control indicates that this phenomenon is not induced by ‘non-spe-
cific’ antibody interactions [28]. Moreover, inhibition of HA at 4°C implies an active, energy-
dependant process.
Fig 4. Anti-CD13mAbs induce neutrophil HA. Neutrophils were incubated with bestatin (0.1 mM), WM-15
or IgG1 (8 μg/ml), WM-47 (1:40 v/v), MY7 (5 μg/ml) or vehicle control. HA was assessed by light microscopy in
duplicate at 37°C and 4°C (A) and flow cytometry (E and F) and data represent the mean ± SEM of n = 3
independent experiments. ***, P < 0.001, **, P < 0.01 vs. control, by two-way ANOVA/Bonferroni test (A).
Representative photomicrographs after 60 min at 37°C (B and C). Original magnification x 50. Representative
SSC area by FSC area dot plots of the fixed neutrophil population separated into singlets and non-singlets
(D). Quantification of neutrophil HA at 30 min. ***, P < 0.001, **, P < 0.01 vs. control, by repeated measures
ANOVA/Dunnett’s test (E and F).
doi:10.1371/journal.pone.0160108.g004
CD13 and Homotypic Aggregation Neutrophils
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The ability of certain anti-CD13 antibodies (WM-15 and MY7) but not others (WM-47) to
induce aggregation may reflect the recognition of different epitopes, which determines the anti-
body’s capacity to cross-link CD13 molecules on the cell membrane. This is evidenced from
studies by Mina-Osorio and colleagues who observed that whole but not Fab fragments of the
antibody 452 induced monocyte-monocyte and monocyte-endothelial adhesion [11, 12]. Con-
sistent with their observations, Fab fragments of WM-15 were incapable of inducing neutrophil
HA (Fig 5A). In contrast, cross-linking of the control mAbWM-47 with F(ab)’2 fragments of a
secondary antibody induced a similar HA response to that of WM-15 alone, confirming that
CD13-mediated neutrophil HA is dependent on mAb cross-linking (Fig 5B).
CD13 has been shown to act as a signal transduction molecule [4]. Cross-linking of mono-
cytic CD13 with WM-15 and MY7 evoked a rise in intracellular calcium that was inhibited by
tyrosine kinase and phosphoinositide 3-kinases (PI3K) inhibitors [29]. Furthermore, treatment
with inhibitors of intracellular kinases, importantly Src family kinases, PI3K and mitogen-acti-
vated protein kinases (MAPK), impaired monocyte HA implying a signal transduction-depen-
dent process [11]. Due to its short cytoplasmic domain, it was assumed that CD13 itself was
Fig 5. CD13-mediated neutrophil HA depends on CD13 cross-linking, involves actin polymerisation
and CD13 directly participates in the adhesive interaction. Neutrophils were pre-incubated for 30 min
with cytochalasin-D (2 μM) or vehicle control prior to the addition of WM-15 (8 or 100 μg/ml), Fab fragments of
WM-15 (8 μg/ml) or buffer (A). Neutrophils were incubated with WM-15 (8 μg/ml) or with WM-47 alone or
followed by a 30 min incubation with F(ab)’2 fragments of GAM antibody (B). HA was assessed at 30 min by
flow cytometry. Data represent the mean ± SEM of at least n = 3 independent experiments (GAM n = 2). ***,
P < 0.001, **, P < 0.01, *, P < 0.05 vs. WM-15, by Student’s unpaired t test (A). ns, non-significant, by
Student’s unpaired t test (B). Neutrophils were pre-incubated with WM-15 (8 μg/ml) or vehicle control for 10
min and added to PBS- or rCD13 (1000 ng/ml) coated wells in duplicate for 20 min. The number of adherent
neutrophils was assessed by light microscopy at 100x magnification. *, P < 0.05 vs. control, by repeated
measures ANOVA/Dunnett’s test (C).
doi:10.1371/journal.pone.0160108.g005
CD13 and Homotypic Aggregation Neutrophils
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inert and that signalling proceeded through its association with unknown auxiliary proteins or
by the regulation of signals initiated by other receptors [4]. However, Subramani et al. have
recently demonstrated, upon mAb cross-linking, the phosphorylation of CD13 itself and its
participation in signalling pathways responsible for increased adhesion [13]. In addition, an
association with cytoskeletal adapter proteins was exhibited [13]. Further evidence for direct
participation of CD13 in the adhesive process was provided by Mina-Osorio and colleagues
who showed that monocyte-endothelial adhesion was impaired by the presence of excess mAb
or soluble CD13 [12].
To determine if CD13 itself participates in the adhesive interaction underlying anti-
CD13-induced neutrophil HA, aggregation was assessed in the presence of excess WM-15. As
shown in Fig 5A, a significant reduction in the HA response was observed with 100 μg/ml
WM-15 suggesting inhibition of a homophilic interaction between neutrophil CD13 molecules.
The finding that WM-15 treated neutrophils, but not resting neutrophils, specifically adhered
to rCD13 further supports a direct CD13-CD13 interaction (Fig 5C). Moreover, WM-
15-induced neutrophil HA was significantly reduced following cytochalasin-D pre-treatment,
suggesting that microfilament assembly and cytoskeletal alterations have a role in increasing
cell adhesiveness (Fig 5A).
To assess the effect of kinase inhibitors on CD13-mediated neutrophil HA, neutrophils
were pre-incubated with the PI3K inhibitor LY294002 and the MEK 1/2 inhibitor UO126.
MEK 1/2 are the immediate upstream activators of extracellular signal-related kinase (ERK 1/
2) [30]. Well-validated concentrations of each inhibitor were taken from previous human neu-
trophil studies to achieve optimal efficacy and selectivity [30, 31]. LY294002 and UO126 inhib-
ited the HA of human neutrophils induced by WM-15 and MY7, suggesting that both PI3K
and ERK 1/2 pathways were involved (Fig 6A and 6B). PI3K and ERK signalling pathways
have previously been shown to be involved in chemoattractant-induced and endothelin-
1-induced neutrophil HA respectively [32, 33].
CD13-mediated HA produces a transmigration deficiency across
collagen I
To determine whether migration through collagen I was impaired as a consequence of anti-
body-induced neutrophil HA, direct observations of cell migration were made according to
previously published techniques [20]. A collagen I gel treated with IL-8 enabled simultaneous
Fig 6. Effect of kinase inhibitors on CD13-mediated neutrophil HA.Neutrophils were pre-incubated for 15 min with LY294002 (10 μM), UO126
(10 μM), or vehicle control prior to the addition of WM-15 (8 μg/ml), WM-47 (1:40 v/v), MY7 (5 μg/ml) or buffer. HA was assessed at 30 min by flow
cytometry. Data represent the mean ± SEM of n = 4 (A) and n = 6 (B) independent experiments. *, P < 0.05, ns, non-significant, by Student’s paired t
test.
doi:10.1371/journal.pone.0160108.g006
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examination of neutrophil migration in response to a gradient of IL-8 together with suitable
surface views that allowed the proportion of added neutrophils entering the gel to be deter-
mined [20]. Consistent with our chemotaxis data, bestatin and WM-15 had no effect on the
mean distance traversed by neutrophils through collagen I over 30 or 60 min (Fig 7A). Neutro-
phil HA was not detected at 30 min and the proportion of cells entering collagen I was similar
across conditions (Fig 7B). At 60 min, however, further entry was inhibited in the WM-15
treated cells and gel surface views at this time showed marked neutrophil HA (Fig 7B and 7D).
Where HA was present, the percentage of cells entering collagen I in response to IL-8 was sig-
nificantly reduced (Fig 7E). Critically, the neutrophils that were able to enter the gel migrated
normally (Fig 7F). With other treatments, neutrophil HA was not identified and neutrophil
entry into collagen I continued to increase between 30 and 60 min (Fig 7B and 7C).
Similar to our polarisation and chemotaxis data, CD13 enzymatic inhibition did not impair
neutrophil migration within collagen I. As outlined above, neutrophil cell surface expression is
Fig 7. Anti-CD13 mAbWM-15 reduces the proportion of neutrophils entering collagen I. Collagen I gels
were equilibrated over 24 hr with IL-8 (100 ng/ml) or media alone (control). Neutrophils were pre-incubated
with bestatin (0.1 mM), WM-15 (8 μg/ml), WM-47 (1:40 v/v) or vehicle control for 10 min and the mean
distance migrated and percentage cells entering the gel assessed with live cell imaging. Data represent the
mean ± SEM of n = 3 independent experiments. ns, non-significant vs. IL-8 control, by two-way ANOVA/
Bonferroni test (A). *, P < 0.05, ns, non-significant vs. 30 min time point, by Student’s paired t test (B).
Representative gel surface images at 60 min showingWM-15-induced neutrophil HA. Original magnification
x 200 (C and D). WM-15 treated neutrophils at 60 min separated according to whether HA was present or not
(E and F). ns, non-significant, by Student’s paired t test.
doi:10.1371/journal.pone.0160108.g007
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lower than for certain other cell types, especially tumour cell lines, and a critical level of CD13
expression may be required for 3D migration [14]. Furthermore, fundamental differences
between neutrophils and tumour cells exist. Tumour cells migrate predominantly in a prote-
ase-dependent mesenchymal manner and the enzymatic activity of CD13 could be anticipated
to play a greater role within these cell types [34]. As a consequence of neutrophil HA, we
observed that anti-CD13 mAbs (WM-15 and MY7) produced a transmigration deficiency
across collagen I by reducing the proportion of cells entering a collagen I gel. The observation
that the formation of cellular aggregates impedes migration has previously been demonstrated;
hence Clostridium perfringens phospholipase C induces heterotypic platelet-neutrophil aggre-
gates, which impair neutrophil movement across an endothelial layer [35].
Concluding remarks
In summary, these data demonstrate the novel observation of HA of human neutrophils in
response to the anti-CD13 antibodies WM-15 and MY7. The HA response is dependent on
mAb cross-linking, is signal transduction-dependent, involving PI3K and ERK 1/2, and
reduces chemoattractant-induced migration through collagen I matrix.
A consequence of ligand binding is that it can induce dimerisation or clustering of receptors
and initiate downstream signalling which may be recapitulated by antibodies [36–38].
Although anti-CD13 mAbs can be used as ligand-mimicking reagents to study CD13-mediated
receptor effects, it remains a receptor without a natural ligand [13]. To date, angiotensin III
and the Met- and Leu-enkephalins are the only recognised in vivo substrates of CD13 and a
putative ligand has not been identified [4, 39]. Support for an endogenous ligand was provided
by Subramani and colleagues who demonstrated the presence of phosphorylated CD13 in peri-
toneal lavage cells taken from mice with thioglycolate-induced peritonitis [13]. Moreover,
Schmidt et al. examined the effect of a specific inflammatory stimulus (Staphylococcus aureus
supernatant) and demonstrated overexpression of neutrophil CD66b and an increase in HA
formation, suggesting that different inflammatory stimuli are capable of inducing different
neutrophil phenotypes [28]. By association specific inflammatory reactions may produce
unique molecules that are capable of binding to and cross-linking CD13, resulting in CD13-de-
pendent inflammation [40].
Homotypic cellular aggregation is an adhesive phenomenon and, when considering the neu-
trophil, has both physiological and pathological sequelae. Physiologically neutrophil aggrega-
tion may be an important mechanism for the intravascular recruitment of neutrophils at sites
of inflammation [41]. Pathologically neutrophil HA can lead to the formation of occlusive
plugs within the microcirculation causing tissue hypoxia, hypoperfusion and endothelial cell
damage [2, 3]. In severe sepsis neutrophil extravasation and migration into underlying tissue is
impaired, possibly as a result of neutrophil aggregation [42]. In contrast to anti-CD13 mAb-
induced HA, chemoattractant-induced neutrophil HA proceeds rapidly and is reversible over a
number of minutes [1]. This property is anticipated to localise the aggregatory response, mini-
mising the potential detrimental effects of neutrophil HA. Our observation that pro-inflamma-
tory mediators increase cell surface expression of CD13 on neutrophils may suggest that CD13
serves to stabilise and prolong neutrophil HA at sites of inflammation. Impaired transmigra-
tion, as demonstrated in this study, would reduce the number of neutrophils able to enter tis-
sues in response to chemoattractants, whilst increasing their intravascular accumulation with
consequent risk of vascular occlusion or endothelial damage. As with other aspects of neutro-
phil function, the balance between beneficial and detrimental effects in inflammation is finely
tuned. CD13 may therefore contribute both physiologically and pathologically to pathways
already defined for inflammatory cell recruitment.
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Supporting Information
S1 Fig. Neutrophil cell surface expression of CD13.Neutrophils were stimulated with fMLP
(100 nM), IL-8 (100 ng/ml), TNF-α (10 ng/ml) or vehicle control for 10 min. Quantification of
mean fluorescence intensity (MFI) (after subtraction of the isotype control) is shown. Data rep-
resent the mean of n = 1 experiment performed in duplicate.
(TIF)
Author Contributions
Conceived and designed the experiments: CAF HP GBN GM ERC. Performed the experiments:
CAF ASC DL. Analyzed the data: CAF. Contributed reagents/materials/analysis tools: GBN
ERC. Wrote the paper: CAF HP GBN GM ERC.
References
1. Simon SI, Chambers JD, Sklar LA. Flow cytometric analysis and modeling of cell-cell adhesive interac-
tions: the neutrophil as a model. J Cell Biol. 1990; 111: 2747–2756. PMID: 2277085
2. Hammerschmidt DE, Harris PD, Wayland JH, Craddock PR, Jacob HS. Complement-induced granulo-
cyte aggregation in vivo. Am J Pathol. 1981; 102: 146–150. PMID: 7468764
3. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, et al. Polymor-
phonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic
period. Stroke J Cereb Circ. 1986; 17: 246–253.
4. Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med.
2008; 14: 361–371. doi: 10.1016/j.molmed.2008.06.003 PMID: 18603472
5. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T. Humanmelanoma invasion and metastasis
enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis. 1995; 13: 337–
344. PMID: 7641419
6. Kehlen A, Lendeckel U, Dralle H, Langner J, Hoang-Vu C. Biological significance of aminopeptidase N/
CD13 in thyroid carcinomas. Cancer Res. 2003; 63: 8500–8506. PMID: 14679016
7. Fukasawa K, Fujii H, Saitoh Y, Koizumi K, Aozuka Y, Sekine K, et al. Aminopeptidase N (APN/CD13) is
selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis. Cancer
Lett. 2006; 243: 135–143. PMID: 16466852
8. Petrovic N, SchackeW, Gahagan JR, O’Conor CA, Winnicka B, Conway RE, et al. CD13/APN regu-
lates endothelial invasion and filopodia formation. Blood. 2007; 110: 142–150. PMID: 17363739
9. Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, et al. Inhibition of APN/CD13 leads to
suppressed progressive potential in ovarian carcinoma cells. BMCCancer. 2007; 7: 140. PMID:
17655775
10. Fujii H, NakajimaM, Aoyagi T, Tsuruo T. Inhibition of tumor cell invasion and matrix degradation by ami-
nopeptidase inhibitors. Biol Pharm Bull. 1996; 19: 6–10. PMID: 8820902
11. Mina-Osorio P, Shapiro LH, Ortega E. CD13 in cell adhesion: aminopeptidase N (CD13) mediates
homotypic aggregation of monocytic cells. J Leukoc Biol. 2006; 79: 719–730. PMID: 16415167
12. Mina-Osorio P, Winnicka B, O’Conor C, Grant CL, Vogel LK, Rodriguez-Pinto D, et al. CD13 is a novel
mediator of monocytic/endothelial cell adhesion. J Leukoc Biol. 2008; 84: 448–459. doi: 10.1189/jlb.
1107802 PMID: 18495788
13. Subramani J, Ghosh M, Rahman MM, Caromile LA, Gerber C, Rezaul K, et al. Tyrosine phosphoryla-
tion of CD13 regulates inflammatory cell-cell adhesion and monocyte trafficking. J Immunol. 2013;
191: 3905–3912. doi: 10.4049/jimmunol.1301348 PMID: 23997214
14. Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human
myeloid cells. Blood. 1990; 75: 462–469. PMID: 1967220
15. Werfel T, Sonntag G, Weber MH, Götze O. Rapid increases in the membrane expression of neutral
endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII
(CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol. 1991; 147:
3909–3914. PMID: 1682387
16. Cowburn AS, Sobolewski A, Reed BJ, Deighton J, Murray J, Cadwallader KA, et al. Aminopeptidase N
(CD13) regulates tumor necrosis factor-alpha-induced apoptosis in human neutrophils. J Biol Chem.
2006; 281: 12458–12467. PMID: 16533817
CD13 and Homotypic Aggregation Neutrophils
PLOS ONE | DOI:10.1371/journal.pone.0160108 July 28, 2016 13 / 15
17. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil
functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol.
1985; 119: 101–110. PMID: 2984939
18. Burton VJ, Butler LM, McGettrick HM, Stone PC, Jeffery HC, Savage CO, et al. Delay of migrating leu-
kocytes by the basement membrane deposited by endothelial cells in long-term culture. Exp Cell Res.
2011; 317: 276–292. doi: 10.1016/j.yexcr.2010.10.022 PMID: 21056557
19. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AAR, et al. Hypoxia
selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.
J Immunol. 2011; 186: 453–463. doi: 10.4049/jimmunol.1002213 PMID: 21135168
20. Luo D, McGettrick HM, Stone PC, Rainger GE, Nash GB. The roles of integrins in function of human
neutrophils after their migration through endothelium into interstitial matrix. PloS One. 2015; 10: (2)
e0118593. doi: 10.1371/journal.pone.0118593 PMID: 25706870
21. Mackenzie DA, Jeffers F, Parker ML, Vibert-Vallet A, Bongaerts RJ, Roos S, et al. Strain-specific diver-
sity of mucus-binding proteins in the adhesion and aggregation properties of Lactobacillus reuteri.
Microbiol Read Engl. 2010; 156: 3368–3378.
22. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes
Infect Inst Pasteur. 2003; 5: 1317–1327.
23. Ashmun RA, Shapiro LH, Look AT. Deletion of the zinc-binding motif of CD13/aminopeptidase N mole-
cules results in loss of epitopes that mediate binding of inhibitory antibodies. Blood. 1992; 79: 3344–
3349. PMID: 1375850
24. Wilkinson PC. Assays of Leukocyte Locomotion and Chemotaxis. J Immunol Methods. 1998; 216:
139–153. PMID: 9760220
25. Yoshikawa T, Dent G, Ward J, Angco G, Nong G, Nomura N, et al. Impaired neutrophil chemotaxis in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175: 473–479. PMID:
17110644
26. Malleret B, Claser C, Ong ASM, Suwanarusk R, Sriprawat K, Howland SW, et al. A rapid and robust tri-
color flow cytometry assay for monitoring malaria parasite development. Sci Rep. 2011; 1: 118. doi: 10.
1038/srep00118 PMID: 22355635
27. Roth S, Franken P, Sacchetti A, Kremer A, Anderson K, SansomO, et al. Paneth cells in intestinal
homeostasis and tissue injury. PloS One. 2012; 7: e38965. doi: 10.1371/journal.pone.0038965 PMID:
22745693
28. Schmidt T, Zündorf J, Grüger T, Brandenburg K, Reiners A-L, Zinserling J, et al. CD66b overexpression
and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive
stimulus. J Leukoc Biol. 2012; 91: 791–802. doi: 10.1189/jlb.0911483 PMID: 22319104
29. Santos AN, Langner J, Herrmann M, Riemann D. Aminopeptidase N/CD13 is directly linked to signal
transduction pathways in monocytes. Cellular Immunology. 2000; 201 (1): 22–32 PMID: 10805970
30. Makni-Maalej K, Chiandotto M, Hurtado-Nedelec M, Bedouhene S, Gougerot-Pocidalo M-A, Dang PM-
C, et al. Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphory-
lation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC,
ERK1/2 and p38MAPkinase. Biochem Pharmacol. 2013; 85: 92–100. doi: 10.1016/j.bcp.2012.10.010
PMID: 23085266
31. Juss JK, Hayhoe RP, Owen CE, Bruce I, Walmsley SR, Cowburn AS, et al. Functional Redundancy of
Class I Phosphoinositide 3-Kinase (PI3K) Isoforms in Signaling Growth Factor-Mediated Human Neu-
trophil Survival. PLoS One. 2012; 7: e45933. doi: 10.1371/journal.pone.0045933 PMID: 23029326
32. Capodici C, Hanft S, Feoktistov M, Pillinger MH. Phosphatidylinositol 3-kinase mediates chemoattrac-
tant-stimulated, CD11b/CD18-dependent cell-cell adhesion of human neutrophils: evidence for an
ERK-independent pathway. J Immunol.1998; 160: 1901–1909. PMID: 9469452
33. József L, Khreiss T, Fournier A, Chan JSD, Filep JG. Extracellular signal-regulated kinase plays an
essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes. Br J
Pharmacol. 2002; 135: 1167–1174. PMID: 11877323
34. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Can-
cer. 2003; 3: 362–374. PMID: 12724734
35. Bryant AE, Bayer CR, Aldape MJ, Wallace RJ, Titball RW, Stevens DL. Clostridium perfringens phos-
pholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. J Med Microbiol.
2006; 55: 495–504. PMID: 16585634
36. Jewell K, Kapron-Bras C, Jeevaratnam P, Dedhar S. Stimulation of tyrosine phosphorylation of distinct
proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins. J
Cell Sci. 1995; 108: 1165–1174. PMID: 7622602
CD13 and Homotypic Aggregation Neutrophils
PLOS ONE | DOI:10.1371/journal.pone.0160108 July 28, 2016 14 / 15
37. Hegen M, Kameoka J, Dong RP, Schlossman SF, Morimoto C. Cross-linking of CD26 by antibody
induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology.
1997; 90: 257–264. PMID: 9135555
38. Liu G, Place AT, Chen Z, Brovkovych VM, Vogel SM, Muller WA, et al. ICAM-1-activated Src and
eNOS signalling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.
Blood. 2012; 120: 1942–1952. doi: 10.1182/blood-2011-12-397430 PMID: 22806890
39. Guzman-Rojas L, Rangel R, Salameh A, Edwards JK, Dondossola E, Kim Y-G, et al. Cooperative
effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor
microenvironment. Proc Natl Acad Sci USA. 2012; 109: 1637–1642. doi: 10.1073/pnas.1120790109
PMID: 22307623
40. Winnicka B, O'Conor C, SchackeW, Vernier K, Grant CL, Fenteany FH, et al. CD13 is dispensable for
normal hematopoiesis and myeloid cell functions in the mouse. J Leukoc Biol. 2010; 88: 347–359. doi:
10.1189/jlb.0210065 PMID: 20430777
41. Rochon YP, Frojmovic MM. A model for the recruitment of neutrophils at sites of inflammation. Physio-
logical relevance of in vivo neutrophil aggregation. Med Hypotheses. 1992; 38: 132–138. PMID:
1528157
42. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development
of multiple organ failure in sepsis. Lancet. 2006; 368: 157–159. PMID: 16829300
CD13 and Homotypic Aggregation Neutrophils
PLOS ONE | DOI:10.1371/journal.pone.0160108 July 28, 2016 15 / 15
